Literature DB >> 31228076

Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.

Ayan Debnath1, Rakesh Kumar Gupta2, Anup Singh3,4.   

Abstract

PURPOSE: To evaluate the role of amide proton transfer-weighted (APT-w) magnetic resonance imaging (MRI) in differentiating neoplastic and infective mass lesions using different contrast normalizations, region of interest (ROI) selection, and histogram analysis. PROCEDURES: Retrospective study included 32 treatment-naive patients having intracranial mass lesions (ICMLs): low-grade glioma (LGG) = 14, high-grade glioma (HGG) = 10, and infective mass lesions = 8. APT-w MRI images were acquired along with conventional MRI images at 3 T. APT-w contrast, corrected for B0-field inhomogeneity, was computed and optimized with respect to different types of normalizations. Different ROIs on lesion region were selected followed by ROI analysis and histogram analysis. Statistical analysis was performed using Shapiro-Wilk's test, t tests, ANOVA with Tukey's post hoc test, and receiver operation characteristic (ROC) analysis.
RESULTS: ICMLs showed significantly (p < 0.01) higher APT-w contrast in lesion compared with contralateral side. There was a substantial overlap between mean APT-w contrast of neoplastic and infective mass lesions as well as among different groups of ICMLs irrespective of ROI selection and normalizations. APT-w contrast (using type 4 normalization: normalized with reference signal at negative offset frequency and APT-w contrast in normal-appearing white matter) reduced variability of APT-w contrast across different subjects, and overlap was less compared with other types of normalizations. There was a significant difference (p < 0.05) between neoplastic and infective mass lesions using t test for different histogram parameters of type 4 normalized APT-w contrast. ANOVA with post hoc showed significant difference (p < 0.05) for different histogram parameters of APT-w contrast (Type 4 normalization) between LGG and HGG, LGG, and infective mass lesion. Histogram parameters such as standard deviation, mean of top percentiles, and median provided improved differentiation between neoplastic and infective mass lesions compared with mean APT-w contrast. A greater number of histogram parameters of type 4 normalized APT-w contrast corresponding to active lesion region can significantly differentiate between ICMLs than other types of normalizations and ROIs.
CONCLUSIONS: APT-w contrast using type 4 normalization and active lesion region (ROI-2) should be used for studying APT. APT-MRI should be combined with other MRI techniques to further improve the differential diagnosis of ICMLs.

Entities:  

Keywords:  Amide proton transfer–weighted; Chemical exchange saturation transfer (CEST); Infective mass lesions; Intracranial mass lesions; MRI; Neoplastic mass lesions

Mesh:

Substances:

Year:  2020        PMID: 31228076      PMCID: PMC7109008          DOI: 10.1007/s11307-019-01382-x

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  35 in total

1.  Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI.

Authors:  Jinyuan Zhou; Jean-Francois Payen; David A Wilson; Richard J Traystman; Peter C M van Zijl
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

2.  Three-dimensional turbo-spin-echo amide proton transfer MR imaging at 3-Tesla and its application to high-grade human brain tumors.

Authors:  Xuna Zhao; Zhibo Wen; Ge Zhang; Fanheng Huang; Shilong Lu; Xianlong Wang; Shuguang Hu; Min Chen; Jinyuan Zhou
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

3.  Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?

Authors:  Hao Yu; Xinrui Wen; Pingping Wu; Yueqin Chen; Tianyu Zou; Xianlong Wang; Shanshan Jiang; Jinyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

4.  CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor.

Authors:  Kejia Cai; Anup Singh; Harish Poptani; Weiguo Li; Shaolin Yang; Yang Lu; Hari Hariharan; Xiaohong J Zhou; Ravinder Reddy
Journal:  NMR Biomed       Date:  2014-10-08       Impact factor: 4.044

5.  Association between pH-weighted endogenous amide proton chemical exchange saturation transfer MRI and tissue lactic acidosis during acute ischemic stroke.

Authors:  Phillip Zhe Sun; Jerry S Cheung; Enfeng Wang; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-09       Impact factor: 6.200

6.  Quantification of amide proton transfer effect pre- and post-gadolinium contrast agent administration.

Authors:  Yee Kai Tee; Manus J Donahue; George W J Harston; Stephen J Payne; Michael A Chappell
Journal:  J Magn Reson Imaging       Date:  2013-11-08       Impact factor: 4.813

7.  Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation.

Authors:  Ji Eun Park; Ho Sung Kim; Kye Jin Park; Sang Joon Kim; Jeong Hoon Kim; Seth A Smith
Journal:  Radiology       Date:  2015-08-19       Impact factor: 11.105

8.  Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.

Authors:  Osamu Togao; Akio Hiwatashi; Koji Yamashita; Kazufumi Kikuchi; Jochen Keupp; Koji Yoshimoto; Daisuke Kuga; Masami Yoneyama; Satoshi O Suzuki; Toru Iwaki; Masaya Takahashi; Koji Iihara; Hiroshi Honda
Journal:  Eur Radiol       Date:  2016-03-22       Impact factor: 5.315

Review 9.  APT-weighted MRI: Techniques, current neuro applications, and challenging issues.

Authors:  Jinyuan Zhou; Hye-Young Heo; Linda Knutsson; Peter C M van Zijl; Shanshan Jiang
Journal:  J Magn Reson Imaging       Date:  2019-01-20       Impact factor: 4.813

10.  Noninvasive amide proton transfer magnetic resonance imaging in evaluating the grading and cellularity of gliomas.

Authors:  Yan Bai; Yusong Lin; Wei Zhang; Lingfei Kong; Lifu Wang; Panli Zuo; Ignacio Vallines; Benjamin Schmitt; Jie Tian; Xiaolei Song; Jinyuan Zhou; Meiyun Wang
Journal:  Oncotarget       Date:  2017-01-24
View more
  4 in total

1.  3D Amide Proton Transfer Weighted Brain Tumor Imaging With Compressed SENSE: Effects of Different Acceleration Factors.

Authors:  Nan Zhang; Haonan Zhang; Bingbing Gao; Yanwei Miao; Ailian Liu; Qingwei Song; Liangjie Lin; Jiazheng Wang
Journal:  Front Neurosci       Date:  2022-05-26       Impact factor: 5.152

2.  Amide proton transfer imaging for differentiation of tuberculomas from high-grade gliomas: Preliminary experience.

Authors:  Karthik Kulanthaivelu; Shumyla Jabeen; Jitender Saini; Sanita Raju; Atchayaram Nalini; Nishanth Sadashiva; Shashank Hegde; Narayana Krishna Rolla; Indrajit Saha; Netravathi M; Seena Vengalil; Saikrishna Swaroop; Shilpa Rao
Journal:  Neuroradiol J       Date:  2021-04-07

3.  Amide Proton Transfer-Weighted (APTw) Imaging of Intracranial Infection in Children: Initial Experience and Comparison with Gadolinium-Enhanced T1-Weighted Imaging.

Authors:  Hong Zhang; Xiaolu Tang; Yanqiu Lv; Di Hu; Jihang Sun; Yan Wang; Jinyuan Zhou; Yun Peng
Journal:  Biomed Res Int       Date:  2020-05-16       Impact factor: 3.411

4.  A Novel Intelligent System for Brain Tumor Diagnosis Based on a Composite Neutrosophic-Slantlet Transform Domain for Statistical Texture Feature Extraction.

Authors:  Shakhawan H Wady; Raghad Z Yousif; Harith R Hasan
Journal:  Biomed Res Int       Date:  2020-07-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.